News - Oncogenes
Almost twelve million -- that’s how many cancer patients are living in the U.S. But what happens when the patients are no longer responsive to the drugs created to treat them? It’s a problem researchers at Case Western Reserve University are working to better understand.
An inexpensive "orphan drug" used to treat sleep disorders appears to be a potent inhibitor of cancer cells.
Some say the number of cases is growing at an epidemic rate! In fact, melanoma is the fastest growing cancer in the U.S.
SAN DIEGO and JERUSALEM, May 17, 2012 /PRNewswire/ -- Ambit Biosciences and Teva Pharmaceutical Industries Limited (NASDAQ: TEVA) ("Teva") today announced the clearance of an Investigational
The human body does a great job of generating new cells to replace dead ones but it is not perfect. Cells need to communicate with or signal to each other to decide when to generate new cells.
